Biothera To Present Predictive Biomarker Data At American Society of Clinical Oncology For Cancer Immunotherapy Imprime PGG
Biothera will present research at the American Society of Clinical Oncology (ASCO) annual meeting linking a potential predictive serum biomarker to the clinical response to Imprime PGG® immunotherapy in a recent phase 2 study in non-small cell lung cancer patients. The meeting begins today and runs through June 3 in Chicago.
Help employers find you! Check out all the jobs and post your resume.